Canadian Cancer Trials Group Bulletins

General


ASCO 2012

A number of abstracts related to Canadian Cancer Trials Group trials or trials which included Canadian Cancer Trials Group participation are being presented at the American Society of Clinical Oncology Annual Meeting in Chicago, June 1-5, 2012, including two that have been chosen as "Best of ASCO"! These include Canadian Cancer Trials Group MA.27 and Canadian Cancer Trials Group HD.8 (EORTC 20012).

Canadian Cancer Trials Group MA.27 - Lois E. Shepherd (included in Best of ASCO program)
Effect of osteoporosis in postmenopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: Canadian Cancer Trials Group MA.27 (Abstract 501)
Oral Abstract Session - Breast Cancer - HER2/ER
Sunday: 8:00 AM - 11:00 AM (Location: N Hall B1)
Presentation Time: 8:30 AM - 8:45 AM

Canadian Cancer Trials Group HD.8 (EORTC 20012)- Patrice P. Carde (included in Best of ASCO program)
ABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup randomized phase III clinical trial(Abstract 8002)
Oral Abstract Session - Lymphoma
Saturday: 3:00 PM - 6:00 PM (Location: E354a)
Presentation Time: 3:45 PM - 4:00 PM

For a complete listing of abstracts being presented, please use this link ... http://www.ctg.queensu.ca/public/publications/ASCO-2012.pdf